Holmium Laser Enucleation of the Prostate (HoLEP) is a surgical procedure used to treat benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland. It involves the use of a laser to remove excess prostate tissue, relieving urinary symptoms caused by BPH.
HoLEP surgery is not known to cause prostate cancer. It is a treatment for a non-cancerous condition and does not increase the risk of developing prostate cancer. However, like any surgical procedure, HoLEP may have potential risks and complications, which should be discussed with your urologist before undergoing the surgery.
Prostate cancer is a separate and distinct condition from BPH. It is a malignant growth of cells in the prostate gland and is not related to the enlargement of the prostate seen in BPH. While HoLEP does not increase the risk of prostate cancer, it is essential for men to be aware of the risk factors for prostate cancer and undergo regular screenings, such as prostate-specific antigen (PSA) tests and digital rectal exams, especially if they are at higher risk due to age, family history, or other factors.
If you have concerns about your prostate health or the risks and benefits of HoLEP surgery, it is important to have a detailed discussion with your urologist. They can provide personalized information and guidance based on your specific medical history and condition. Regular follow-ups and screenings after the surgery are also crucial to monitor your prostate health.